*Dr. Seena K. Sivan and Dr. Seena A. R.


Anaplastic large cell lymphoma (ALCL) consist of a proliferation of predominantly large lymphoid cells with strong expression of cytokine receptor CD30. Two major groups of ALCL have been described. First is a spectrum of CD30+ T cell lymphoproliferative disorder. Second is systemic nodal ALCL which is again subdivided into anaplastic lymphoma kinase (ALK) positive and ALK negative systemic ALCL. ALK expression is caused by chromosomal translocation most commonly t(2;5). We report the case of a 55 year old male presented with pain in right elbow. He had an enlarged left supraclavicular node. Xray showed a lytic lesion in supracondylar region of Right Humerus. Scanning revealed multiple enlarged nodes in mediastinum. Fine needle aspiration cytology from both the sites were showing scattered cells with marked nuclear atypia, multinucleation, prominent nucleoli and varying amounts of cytoplasm. Morphologically the cells, especially because they showed clustering in areas, were suggestive of Carcinoma cells, but multiple nodes being involved, suggested a Lymphoma. Biopsy was advised for a definite opinion. Biopsy from both the sites have showed diffuse sheets of pleomorphic cells, binucleate and multinucleate cells with moderate to abundant cytoplasm. Also noted cells with prominent eosinophilic nucleoli (RS like cells) and cells with reniform nucleus. Marker studies revealed that these cells are negative for Cytokeratin and LCA positive. Next line of markers included CD 30, CD 15, PAX-5 and EMA, of which PAX-5 was negative, thus ruling out Hodgkins Lymphoma. EMA was faint and focal positive. Epithelial like cells and RS like cells along with reinform nucleus were suggestive of Anaplastic large cells lymphoma(ALCL). EMA positivity was also supported this. ALK staining was done and found to be negative. Here the case was reported as ALK negative Anaplastic Large Cell Lymphoma. Unlike ALK positive Anaplastic Large Cell Lymphoma, this type is seen in fourth and sixth decades. Both nodal and extranodal sites like bone, soft tissue and skin are affected. Cells may show cohesive pattern mimicking carcinoma. Prognosis is poorer than ALCL-ALK positive cases.

Keywords: ALK negative, anaplastic large cell lymphoma, immunohistochemistry, PAX 5 negativity, bony and cutaneous lesions.[3]

[Full Text Article]


Forgot Password  |  Register


Best Paper Awards

European Journal of Biomedical and Pharmaceutical Sciences (EJBPS) will give best paper award in every issue in the form of money along with certificate to promote research activity of scholar.

Best Article of current issue :

Tangudu Nagabhusana Rao

Download Article : Click here

News & Updation


    JANUARY 2020 Issue has been successfully launched on 1 January 2020.

  • EJBPS New Impact Factor

    Its our Pleasure to Inform you that EJBPS Impact Factor has been increased from 5.467 to 6.044, due to high quality Publication at International Level.

  • Index Copernicus Value

    EJBPS Received Index Copernicus Value 77.3, due to High Quality Publication in EJBPS at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.


  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in EJBPS coming Issue.


UG/PG/Ph.D Research Publication

Research Scholar of UG/PG/Ph.D can Submit their Research Article/Review Article/Case Study/Short Communication for Publication in EJBPS


Copyright From

Covering Letter

                        Author Instruction